The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths

被引:19
|
作者
Tang, Sunny X. [1 ]
Moore, Tyler M. [1 ]
Calkins, Monica E. [1 ]
Yi, James J. [1 ,3 ]
Savitt, Adam [1 ]
Kohler, Christian G. [1 ]
Souders, Margaret C. [4 ]
Zackai, Elaine H. [2 ,4 ]
McDonald-McGinn, Donna M. [2 ,4 ]
Emanuel, Beverly S. [2 ,4 ]
Gur, Ruben C. [1 ]
Gur, Raquel E. [1 ,3 ]
机构
[1] Univ Penn, Dept Psychiat, Perelman Sch Med, 10th Floor Gates Bldg,3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Clinical high risk; DiGeorge syndrome; Prodromal; Psychosis; 22q11.2 Deletion syndrome; Schizophrenia; DEFICIT HYPERACTIVITY DISORDER; SCHOOL-AGE-CHILDREN; ULTRA-HIGH RISK; FOLLOW-UP; INTERRATER RELIABILITY; PSYCHIATRIC-DISORDERS; PRODROMAL SYNDROMES; SCHIZOPHRENIA; SYMPTOMS; ADOLESCENTS;
D O I
10.1016/j.biopsych.2016.08.034
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Chromosome 22q11.2 deletion syndrome (22q11DS) is a promising model for studying psychosis risk. Direct comparisons of psychosis features between 22q11DS and nondeleted (ND) individuals are limited by inconsistency and small samples. In the largest study to date, we compare 22q11DS to ND in comorbidities, functioning, cognition, and psychosis features across the full range of overall severity. METHODS: ND youths (n = 150) ages 9 to 24 years were matched to 22q11DS individuals (n = 150) on age and sex, stratifying for presence of psychosis spectrum disorder. Individuals were evaluated for psychosis using the Structured Interview for Prodromal Syndromes, and for attention-deficit/hyperactivity, substance-related, and mood disorders. Differential item functioning analysis addressed whether 22q11DS differs from ND in the probability of clinically significant ratings while holding constant the overall level of psychosis. RESULTS: Onset of psychosis proneness was similar among 22q11DS (mean: 11.0 years) and ND (mean: 12.1 years) individuals. Accounting for higher overall psychosis symptoms, 22q11DS participants were still more likely to manifest impaired stress tolerance, avolition, and ideational richness; ND individuals were more likely to exhibit unusual thoughts, persecutory ideas, and bizarre thinking. Cognition was impaired in 22q11DS, but it did not correlate with symptoms except ideational richness. Comorbid anxiety disorders were more likely in psychosis spectrum 22q11DS; substance-related disorders were more likely in ND. Global assessment of function was similar in 22q11DS and ND individuals, except among those with low total Structured Interview for Prodromal Syndromes scores. CONCLUSIONS: Individuals with 22q11DS share overarching similarities with ND individuals in psychosis symptoms and age of onset for psychosis proneness; this continues to support the 22q11DS model as a valuable window into mechanisms contributing to psychosis.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [31] Metyrosine in psychosis associated with 22q11.2 deletion syndrome: Case report
    Carandang, Carlo G.
    Scholten, Monique C.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (01) : 115 - 120
  • [32] Case Report: Autoimmune Psychosis in Chromosome 22q11.2 Deletion Syndrome
    Ciano-Petersen, Nicolas Lundahl
    Hamad-Cueto, Omar
    Drissi-Reyes, Hania
    Dona-Diaz, Alvaro
    Garcia-Martin, Guillermina
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study
    Weisman, Omri
    Guri, Yael
    Gur, Raquel E.
    McDonald-McGinn, Donna M.
    Calkins, Monica E.
    Tang, Sunny X.
    Emanuel, Beverly
    Zackai, Elaine H.
    Eliez, Stephan
    Schneider, Maude
    Schaer, Marie
    Kates, Wendy R.
    Antshel, Kevin M.
    Fremont, Wanda
    Shashi, Vandana
    Hooper, Stephen R.
    Armando, Marco
    Vicari, Stefano
    Pontillo, Maria
    Kushan, Leila
    Jalbrzikowski, Maria
    Bearden, Carrie E.
    Cubells, Joseph F.
    Ousley, Opal Y.
    Walker, Elaine F.
    Simon, Tony J.
    Stoddard, Joel
    Niendam, Tara A.
    van den Bree, Marianne B. M.
    Gothelf, Doron
    SCHIZOPHRENIA BULLETIN, 2017, 43 (05) : 1079 - 1089
  • [34] 22Q11.2 Deletion syndrome as a framework to better understand the development of psychosis
    Schneider, M.
    Eliez, S.
    Gothelf, D.
    Armando, M.
    Fonseca-pedrero, E.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S75 - S76
  • [35] Psychosis spectrum features, neurocognition and functioning in a longitudinal study of youth with 22q11.2 deletion syndrome
    Gur, Raquel E.
    McDonald-McGinn, Donna M.
    Moore, Tyler M.
    Gallagher, R. Sean
    McClellan, Emily
    White, Lauren
    Ruparel, Kosha
    Hillman, Noah
    Crowley, T. Blaine
    McGinn, Daniel E.
    Zackai, Elaine
    Emanuel, Beverly S.
    Calkins, Monica E.
    Roalf, David R.
    Gur, Ruben C.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (14) : 6763 - 6772
  • [36] Defining the clinical spectrum of deletion 22q11.2
    Robin, NH
    Shprintzen, RJ
    JOURNAL OF PEDIATRICS, 2005, 147 (01): : 90 - 96
  • [37] The spectrum of the chromosome 22q11.2 deletion.
    McDonald-McGinn, DM
    LaRossa, D
    Randall, P
    Goldmuntz, E
    Clarke, BJ
    Sullivan, K
    Eicher, P
    Lynch, D
    Binghsm, P
    Wang, P
    Gerdes, M
    Moss, E
    Solot, C
    Moshang, T
    Ming, JE
    Driscoll, D
    Emanuel, BS
    Zackai, EH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A106 - A106
  • [38] Computer-Vision Analysis of Craniofacial Dysmorphology in 22q11.2 Deletion Syndrome and Psychosis Spectrum Disorders
    Roalf, David
    McDonald-Mcginn, Donna
    Jee, Joelle
    Krall, Mckenna
    Crowley, T. Blaine
    Moberg, Paul
    Kohler, Christian
    Bailey, Alice
    Calkins, Monica
    Campbell, Ian
    Clark, Kelly
    Crow, Andrew
    Fleischer, Nicole
    Gallagher, R. Sean
    Gozenbach, Virgil
    Gur, Ruben
    McClellan, Emily
    McGinn, Daniel
    Mordy, Arianna
    Ruparel, Kosha
    Shinohara, Russell
    Turetsky, Bruce
    White, Lauren
    Zackai, Elaine
    Gur, Raquel
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 359 - 359
  • [39] Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders
    Roalf, David R.
    McDonald-McGinn, Donna M.
    Jee, Joelle
    Krall, Mckenna
    Crowley, T. Blaine
    Moberg, Paul J.
    Kohler, Christian
    Calkins, Monica E.
    Crow, Andrew J. D.
    Fleischer, Nicole
    Gallagher, R. Sean
    Gonzenbach, Virgilio
    Clark, Kelly
    Gur, Ruben C.
    Mcclellan, Emily
    Mcginn, Daniel E.
    Mordy, Arianna
    Ruparel, Kosha
    Turetsky, Bruce I.
    Shinohara, Russell T.
    White, Lauren
    Zackai, Elaine
    Gur, Raquel E.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2024, 16 (01)
  • [40] Computer-Vision Analysis of Craniofacial Dysmorphology in 22q11.2 Deletion Syndrome and Psychosis Spectrum Disorders
    Roalf, David
    McDonald-Mcginn, Donna
    Jee, Joelle
    Krall, Mckenna
    Crowley, T. Blaine
    Moberg, Paul
    Kohler, Christian
    Bailey, Alice
    Calkins, Monica
    Campbell, Ian
    Clark, Kelly
    Crow, Andrew
    Fleischer, Nicole
    Gallagher, R. Sean
    Gozenbach, Virgil
    Gur, Ruben
    McClellan, Emily
    McGinn, Daniel
    Mordy, Arianna
    Ruparel, Kosha
    Shinohara, Russell
    Turetsky, Bruce
    White, Lauren
    Zackai, Elaine
    Gur, Raquel
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 359 - 359